Dispatch Bio, co-founded by Carl June, MD, the Richard W. Vague Professor in Immunotherapy at Penn Medicine, is developing a treatment for solid tumors that combines immunotherapy with a tumor-specific virus. The technology, now in preclinical development, has the potential to overcome the limitations of traditional cancer treatments for solid tumors and to offer treatment to a broader range of patients. Read more here.